A retrospective study of the chemomobilization effect of AAE regime plus rhG-CSF in acute leukemia patients

被引：0
|
作者：
Shi, J. [1 ]
Luo, Y. [2 ]
Tan, Y. [2 ]
Huang, H. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB028
引用
收藏
页码：5565 / 5565
页数：1
相关论文
共 50 条
  • [21] Treatment of poor prognosis AML with rhGM-CSF and rhG-CSF for priming, followed by cytarabine plus mitoxantrone induction therapy: A phase I/II study.
    Mantovani, L
    Kampfe, D
    Lehmann, P
    Ponisch, W
    Leiblein, S
    Wolkersdorf, G
    Schulze, F
    Schwenke, H
    Helbig, W
    BLOOD, 1995, 86 (10) : 3062 - 3062
  • [22] In vivo priming with rhG-CSF increases the expression of CD33 in acute myeloid leukemia blast cells and possibly enhances the cytotoxic effect of Gemtuzumab-Ozamicin: Results of a pilot study.
    Leone, G
    Rutella, S
    Scardocci, A
    Voso, MT
    Pagano, L
    BLOOD, 2003, 102 (11) : 256B - 256B
  • [23] Clinical observation on prevention of chemotherapy infection in gastric cancer by moxa-stick moxibustion plus rhG-CSF and its effect on immune function
    Zhang Huan-huan
    Shen Lei
    JOURNAL OF ACUPUNCTURE AND TUINA SCIENCE, 2020, 18 (02) : 116 - 121
  • [24] Advantages of prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: An open-label, randomized, multicenter phase III study
    Xie, Jie
    Cao, Jun
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Sheng
    Wang, Leiping
    Zhang, Jian
    Tao, Zhonghua
    Li, Ting
    Zhang, JinFeng
    Hu, Xi-Chun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Decitabine combined with low-dose cytarabine, aclarubicin and rhG-CSF regimen may be a potential alternative for relapsed/refractory acute myeloid leukemia: A single-center study
    Fu, Yu
    Su, Long
    Li, Yuying
    Tan, Yehui
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023,
  • [26] Mobilization at blood progenitor cells (BPC) in patients with chronic myelogenous leukemia (CML) receiving alfa-interferon (IFN) using RHG-CSF
    Carreras, E
    Mazzara, R
    Sole, F
    Sierra, J
    Rovira, M
    UrbanoIspizua, A
    Merino, A
    Colomer, D
    Feliz, P
    Monfort, N
    Marin, P
    Montserrat, E
    Rozman, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 307 - 307
  • [27] Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
    Jie Xie
    Jun Cao
    Jing-fen Wang
    Bai-hong Zhang
    Xiao-hua Zeng
    Hong Zheng
    Yang Zhang
    Li Cai
    Yu-dong Wu
    Qiang Yao
    Xiao-chun Zhao
    Wei-dong Mao
    Ai-Mei Jiang
    Shao-shui Chen
    Shun-e Yang
    Shu-sen Wang
    Jian-hong Wang
    Yue-yin Pan
    Bi-yong Ren
    Yan-ju Chen
    Li-zhi Ouyang
    Kai-jian Lei
    Jing-hua Gao
    Wen-he Huang
    Zhan Huang
    Tao Shou
    Yan-ling He
    Jing Cheng
    Yang Sun
    Wei-ming Li
    Shu-de Cui
    Xin Wang
    Zhi-guo Rao
    Hu Ma
    Wei Liu
    Xue-yong Wu
    Wei-xi Shen
    Fei-lin Cao
    Ze-min Xiao
    Biao Wu
    Shu-yan Tian
    Dong Meng
    Peng Shen
    Bi-yun Wang
    Zhonghua Wang
    Jian Zhang
    Leiping Wang
    Xi-chun Hu
    Breast Cancer Research and Treatment, 2018, 168 : 389 - 399
  • [28] Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
    Xie, Jie
    Cao, Jun
    Wang, Jing-fen
    Zhang, Bai-hong
    Zeng, Xiao-hua
    Zheng, Hong
    Zhang, Yang
    Cai, Li
    Wu, Yu-dong
    Yao, Qiang
    Zhao, Xiao-chun
    Mao, Wei-dong
    Jiang, Ai-Mei
    Chen, Shao-shui
    Yang, Shun-e
    Wang, Shu-sen
    Wang, Jian-hong
    Pan, Yue-yin
    Ren, Bi-yong
    Chen, Yan-ju
    Ouyang, Li-zhi
    Lei, Kai-jian
    Gao, Jing-hua
    Huang, Wen-he
    Huang, Zhan
    Shou, Tao
    He, Yan-ling
    Cheng, Jing
    Sun, Yang
    Li, Wei-ming
    Cui, Shu-de
    Wang, Xin
    Rao, Zhi-guo
    Ma, Hu
    Liu, Wei
    Wu, Xue-yong
    Shen, Wei-xi
    Cao, Fei-lin
    Xiao, Ze-min
    Wu, Biao
    Tian, Shu-yan
    Meng, Dong
    Shen, Peng
    Wang, Bi-yun
    Wang, Zhonghua
    Zhang, Jian
    Wang, Leiping
    Hu, Xi-chun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 389 - 399
  • [29] PHASE I-II STUDY OF RHG-CSF IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER
    BRONCHUD, MH
    DEXTER, TM
    THATCHER, N
    SCARFFE, JH
    BRITISH JOURNAL OF CANCER, 1988, 57 (02) : 232 - 232
  • [30] Comparison of granulocyte-colony stimulating factor (rhG-CSF) mobilized peripheral blood stem cells (PBSC) and bone marrow for autologous transplantation in patients with acute myelogenous leukemia (AML)
    Demirer, T
    Bensinger, WI
    Rowley, S
    Appelbaum, FR
    Petersen, FB
    Chauncey, T
    Fefer, A
    Buckner, CD
    BLOOD, 1995, 86 (10) : 381 - 381
12345